CELERY SEED 1G1EAA320L 20.00%
MEDICAGO SATIVA WHOLE DJO934BRBD 20.00%
CHICORY ROOT 090CTY533N 18.00%
GLUCOSAMINE HYDROCHLORIDE 750W5330FY 10.00%
BUCKWHEAT N0Y68724R3 7.00%
TEA LEAF GH42T47V24 5.00%
PUERARIN Z9W8997416 5.00%
MORUS ALBA LEAF M8YIA49Q2P 3.00%
LICORICE 61ZBX54883 0.20%
SODIUM CHLORIDE 451W47IQ8X 2.00%
This product has a significanteffect on gout, crystal deposits,and hyperuricemia;
elt has an auxiliary effectof mitigating kidney stonesand bladder stones
Keep out of reach of children
The product has great somatosensation after taking it atleast 21 days in the earty stage;3. Elevated uric acid or gout recurrence and site changes arenoral in the earty stage of taking this product;
Dissolved CrystallizationKidney StoneGallstone< Urinary Calculus
For your health, please read the followingcarefully
1. The use of three vials can effectivety dissolve crystallization (ittakes time to dissolve crystallization);2. The product has great somatosensation after taking it atleast 21 days in the early stage;3. Elevated uric acid or gout recurrence and site changes arenormal in the early stage of taking this product;4. Try not to drink alcohol or drink less 15 days before takingthis product;
5. This product certainly has significant effect on gout,crystallization and hyperuricemia;
Do not use if seal is broken.
Do not eat freshness packet enclosed.
Keep out of direct sunlight, high temperature, and humidity.
Store in a cool, dry place.
MICROCRYSTALLINE CELLULOSE
MALTOSYL-ISOMALTOTETRAOSE
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED
MAGNESIUM STEARATE
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85631-003-01 | Gout Relief 3310-S | 1.3 g in 1 CAPSULE | CAPSULE | 1.3 | 2 | |
| 85631-003-01 | Gout Relief 3310-S | 60 in 1 BOX | CAPSULE | 60 | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 85631-003 | 85631-003-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GLUCOSAMINE HYDROCHLORIDE | 750W5330FY | ACTIB |
| MORUS ALBA LEAF | M8YIA49Q2P | ACTIB |
| LICORICE | 61ZBX54883 | ACTIB |
| PUERARIN | Z9W8997416 | ACTIB |
| BUCKWHEAT | N0Y68724R3 | ACTIB |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
| MEDICAGO SATIVA WHOLE | DJO934BRBD | ACTIB |
| TEA LEAF | GH42T47V24 | ACTIB |
| CELLULOSE GUM | K679OBS311 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| CELERY SEED | 1G1EAA320L | ACTIB |
| MALTOSYL-ISOMALTOTETRAOSE | B9HR7A9UFR | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| CHICORY ROOT | 090CTY533N | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gout Relief 3310-S | CELERY SEED, MEDICAGO SATIVA WHOLE,CHICORY ROOT | Bispit Canada Ltd. | 3afaa7d9-3de3-52d9-e063-6294a90a54ec | 2025-08-02 | Warnings | 85631-003-01 85631-003 85631000301 3b610399-6dbe-c84f-e063-6394a90afd5e 3afaa7d9-3de3-52d9-e063-6294a90a54ec |
Adverse event summaries are temporarily unavailable. Other product information remains available.